PharmaPulse tracks regulatory filings, trial updates, pipeline announcements, and commercial moves across every major market. Automatically. So you never get caught off guard again.
PharmaPulse pulls from regulatory databases, trial registries, company filings, scientific journals, and commercial intelligence feeds.
FDA approvals, Complete Response Letters, EMA opinions, Health Canada decisions, MHRA actions. Every major agency, globally.
New registrations, phase transitions, enrollment milestones, protocol amendments, and completion date changes across ClinicalTrials.gov and EU CTR.
BLA, NDA, sNDA, MAA, and supplemental submissions. PDUFA dates. Advisory committee announcements. Label updates.
Major journal publications, NEJM and Lancet readouts, preprint releases, label expansions, and key data presentations.
In-licensing deals, asset acquisitions, program discontinuations, indication expansions, and strategic partnership announcements.
Field force changes, formulary wins, market access updates, earnings call highlights, and leadership appointments tied to key programs.
Real signal types from our monitoring system. The kind of thing that lands in your inbox before anyone on your team has seen it.
No onboarding calls. No professional services. No 90-day implementation. You tell us what you're watching and we start immediately.
Enter the drugs, companies, or disease areas you monitor. Add geographic markets if relevant. Takes about two minutes.
PharmaPulse continuously monitors 40+ data sources across regulators, trial registries, scientific journals, financial filings, and more.
Alerts land in your inbox with context built in. Not just the news but what it means, why it matters, and what your competitors might do next.
Cancel any time. No onboarding fees. No annual commitments unless you want one.
Start monitoring for free. No credit card. Signals start within minutes of setup.
No spam. No sales calls. Unsubscribe any time.